Ganciclovir Sodium

   
Google
 
Web NewDrugInformation.com

Ganciclovir Sodium


Drug - Ganciclovir Sodium
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ganciclovir Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 500MG BASE/VIAL
The potency of the active ingredient(s), Ganciclovir Sodium. May repeat for multiple part products.

Applicant - BEDFORD
The firm name holding legal responsibility for Ganciclovir Sodium. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076222
The FDA assigned number to Ganciclovir Sodium. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ganciclovir Sodium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 16, 2003
The date Ganciclovir Sodium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ganciclovir Sodium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ganciclovir Sodium is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bedford Laboratories Div Ben Venue Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Ganciclovir Sodium.

Ganciclovir Sodium